January 4, 2008Open Access
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Key Points
Key points are not available for this paper at this time.
Abstract
Aspergillus species have emerged as an important cause of life-threatening infections in immunocompromised patients. This expanding population is composed of patients with prolonged neutropenia, advanced HIV infection, and inherited immunodeficiency and patients who have undergone allogeneic hematopoietic stem cell transplantation (HSCT) and/or lung transplantation. This document constitutes the guidelines of the Infectious Diseases Society of America for treatment of aspergillosis and replaces the practice guidelines for Aspergillus published in 2000 The objective of these
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
T
Thomas J. Walsh
Rutgers, The State University of New Jersey
E
Elias Anaissie
University of Arkansas at Little Rock
David W. Denning
Statens Serum Institut
Journals
Clinical Infectious Diseases
Actions
Institutions
Stanford University
National Cancer Institute
The University of Texas MD Anderson Cancer Center
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...